Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AVR · against 1,336 other Healthcare companies
Ranked #953 of 1,337 · scores higher than 8% of peers
Bars: peers in each 10-point band of the valuation score385 peers with a valuation score of 0–9, including AVR · Click a bar to see the companies
Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | AVR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -34.8% | 1.5% | 7% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | -35.7% | 4.2% | 7% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -16.2% | -1.0% | 19% | 20% | |
| Book yieldHigher is better · 1,306 reported | 46.1% | 37.9% | 59% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 953 | 82M USD | 8 | 27 | |
| 953 | 647M USD | 8 | 40 | |
| 953 | 377M USD | 8 | 29 | |
| 953 | 334M USD | 8 | 36 | |
| 953 | 546M USD | 8 | 31 | |
| 953 | 2.9B USD | 8 | 44 | |
| 953 | 7.3B USD | 8 | 32 | |
| 953 | 14.5B USD | 8 | 30 | |
| 953 | 815M USD | 8 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score